Long-term health · 5 min read
Menopause and heart disease: why risk rises and what to do
Why heart disease risk climbs around menopause, which numbers to track in your 40s and 50s, and the steps with the strongest evidence for lowering your risk.
Heart disease risk rises after menopause, partly because of age and partly because the transition itself shifts cholesterol, body fat and blood vessel health in an unfavorable direction. Heart disease is the leading cause of death for US women, yet most of the risk factors behind it can be measured in your 40s and treated long before they cause harm. The practical move is to know your numbers now and act on the ones that are drifting.
Why risk rises around menopause
For decades, doctors noticed that women develop coronary heart disease several years later than men and wondered whether menopause was the turning point. Long-term studies that followed women through the transition, such as the Study of Women’s Health Across the Nation (SWAN), allowed researchers to separate the effect of getting older from the effect of the ovaries winding down.
The American Heart Association’s 2020 scientific statement summarized what they found. Across the menopause transition, women show distinct changes in sex hormones along with adverse shifts in:
- Cholesterol and other lipids. LDL cholesterol and apolipoprotein B rise most steeply around the final menstrual period. Our guide to cholesterol changes in perimenopause gives the figures.
- Body composition. Fat mass tends to rise and lean mass to fall, even when the scale barely moves.
- Vascular health. Measures of blood vessel health change for the worse.
The statement’s conclusion is that midlife is a time of accelerating risk and therefore a critical window for early prevention. It also noted that the most recent sex-specific AHA prevention guidelines, from 2011, did not reflect this research.
The numbers
According to the CDC, heart disease caused the deaths of 304,970 US women in 2023, about 1 in every 5 female deaths. Only about 56% of women recognize it as their leading cause of death.
The age at which menopause happens matters. In a UK Biobank analysis of 144,260 postmenopausal women followed for a median of 7 years, cardiovascular events (a composite including coronary disease, heart failure, atrial fibrillation, stroke and blood clots) occurred at these rates:
| Group | Events per 1,000 women per year | Adjusted hazard ratio |
|---|---|---|
| No premature menopause | 5.70 | 1.00 (reference) |
| Natural menopause before 40 | 8.78 | 1.36 |
| Surgical menopause (both ovaries removed) before 40 | 11.27 | 1.87 |
The hazard ratios were adjusted for conventional risk factors and hormone therapy use. The authors called the increase small but statistically significant. If this applies to you, see our guide to premature ovarian insufficiency.
Checks worth doing in your 40s and 50s
| What to measure | Why it matters |
|---|---|
| Blood pressure | Nearly half of US women have high blood pressure; see blood pressure in midlife women |
| Lipid panel | LDL cholesterol rises around the final period |
| Lipoprotein(a), once | Largely inherited; the 2026 cholesterol guideline recommends measuring it at least once in every adult |
| A1C or fasting glucose | Diabetes raises heart risk |
| Weight and waist | Body fat tends to rise across the transition |
| 10-year risk estimate | Combines the above to guide treatment |
Risk calculators have changed. The 2026 ACC/AHA dyslipidemia guideline replaced the older Pooled Cohort Equations with the AHA’s PREVENT equations, which estimate 10-year and 30-year risk for adults aged 30 to 79 and include kidney function. The guideline sorts 10-year risk into low (under 3%), borderline (3% to under 5%), intermediate (5% to under 10%) and high (10% or more).
Women’s history counts. The same guideline asks clinicians to record reproductive risk markers, including premature or early menopause, preeclampsia, gestational diabetes, gestational hypertension and preterm delivery. These can tip a borderline decision toward treatment. If the decision is still unclear, a coronary artery calcium scan can help reclassify risk in women 45 and older.
What lowers risk
The AHA’s Life’s Essential 8 framework lists the eight factors that best capture heart health: diet, physical activity, nicotine exposure, sleep, body mass index, blood lipids, blood glucose and blood pressure. Each is scored from 0 to 100, and the average gives an overall cardiovascular health score. It is a useful checklist because every item can be changed.
The CDC’s practical version for women:
- Know your blood pressure and check it regularly.
- Get tested for diabetes and have cholesterol and triglycerides checked.
- Quit smoking.
- Get at least 150 minutes of physical activity a week; strength training counts toward a healthy body composition.
- Choose foods that help manage weight; a Mediterranean-style pattern is well studied.
- Limit alcohol to one drink a day or less.
- Find healthy ways to manage stress.
Sleep is now part of the AHA’s definition of heart health, which matters in a life stage when night sweats and early waking are common.
When lifestyle is not enough, medications are effective. Statins lower LDL cholesterol, and blood pressure drugs lower stroke and heart attack risk. The thresholds for starting them depend mainly on your calculated risk, with factors such as early menopause used to refine borderline cases.
Where hormone therapy fits
Hormone therapy treats hot flashes and night sweats; it is not a heart medicine. The Menopause Society’s 2022 position statement says it is not approved for primary or secondary prevention of cardiovascular disease.
Timing shapes the picture. For healthy women under 60 or within 10 years of menopause, the statement says the favorable effects of hormone therapy on coronary heart disease and all-cause mortality should be weighed against rare increases in breast cancer, blood clots and stroke. For women who start more than 10 years after menopause or after 60, the balance is less favorable because absolute risks of coronary heart disease, stroke, blood clots and dementia are higher. Women with prior heart disease, stroke or blood clots generally should not use systemic hormone therapy.
For the full picture, read is hormone therapy safe?.
When to see a clinician
Call 911 for chest pain or pressure, or for upper back or neck pain, indigestion, nausea, extreme fatigue, dizziness or shortness of breath that comes on suddenly. Women can have heart attack symptoms other than chest pain.
Book a visit if you have not had your blood pressure, cholesterol and blood sugar checked in the past few years, if your periods stopped before 45, if you had preeclampsia or gestational diabetes, or if a close relative had early heart disease. Ask your clinician to calculate your 10-year risk and explain what would change it. Racing or skipped beats are common in perimenopause and usually harmless, but palpitations with fainting or chest pain need prompt care.
Bring a list of your numbers and your reproductive history. You can search for a menopause-literate clinician in our directory.
Frequently asked questions
Does menopause cause heart disease?
Not on its own. Risk rises with age in both sexes, but long-term studies of women followed through the transition show that menopause itself is accompanied by adverse changes in cholesterol, body composition and blood vessel function. Women typically develop coronary heart disease several years later than men, and those years are the best time to act.
Should I take hormone therapy to protect my heart?
No, not for that reason alone. The Menopause Society states that hormone therapy is not approved for preventing heart disease. For healthy women under 60 or within 10 years of menopause who take it for symptoms, its effects on heart disease and overall mortality appear favorable, but starting after 60 or more than 10 years past menopause carries greater absolute risks of heart disease, stroke and blood clots.
Which heart tests should I ask for in perimenopause?
A blood pressure reading, a lipid panel, a one-time lipoprotein(a) test, and a blood sugar test such as A1C cover the basics. Your clinician can combine these with age, smoking and kidney function to estimate your 10-year risk with the PREVENT calculator. A coronary artery calcium scan is an option for some women 45 and older when the decision about a statin is unclear.
Are heart attack symptoms different in women?
Chest pain or pressure is still the most common symptom, but women may also have upper back or neck pain, indigestion, heartburn, nausea or vomiting, extreme fatigue, dizziness or shortness of breath. If you have these symptoms, call 911 rather than waiting to see if they pass.
Sources
- CDC. Women and Heart Disease
- El Khoudary SR et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation, 2020
- Honigberg MC et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA, 2019
- Writing Committee Members (Blumenthal RS et al.). 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2026
- Lloyd-Jones DM et al. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation, 2022
- The North American Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause, 2022